NCT07284446Recruiting
Depressive Symptoms, Cognitive Impairment, and Outcomes in Hospitalized Chronic Heart Failure Patients
Prevalence of Depressive Symptoms and Cognitive Impairment and Their Association With Worse Outcomes in a Cohort of Hospitalized Patients With Chronic Heart Failure
Source: ClinicalTrials.gov · Last updated 16 Dec 2025
Brief summary (registry, in English)
The goal of this observational study is to learn about the prevalence of depressive symptoms and cognitive impairment and their association with worse outcomes in a cohort of hospitalized patients between the ages of 18 ang 85 years with chronic heart failure. The main question it aims to answer is: • Does the presence of depressive symptoms and cognitive impairment lead to worse outcomes in a cohort of hospitalized patients with chronic heart failure? Participants who are hospitalized due to exacerbation of chronic heart failure will answer survey questions to assess their cognitive function and depressive symptoms.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 22 Nov 2025
- Start date
- Dec 2025
- Primary completion date
- Dec 2028
- Lead sponsor
- Lithuanian University of Health Sciences
- Diseases
- Heart failure
- NCT number
- NCT07284446
What you commit to
- Study type: Observational
- Planned participants: 300
- From Dec 2025 to the primary completion date, Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- hospitalization for acute heart failure;
- severe visual impairment preventing completion of the visual part of the Montreal Cognitive Assessment;
Other
- total length of hospital stay \<96 hours;
- absence of transthoracic echocardiography (TTE) within the last 12 months and no TTE planned;
- refusal to participate.
Who the study is looking for
- patient hospitalized primarily for CHF exacerbation;
- clinically stable, able to provide informed consent;
- do not have severe cognitive impairment that would preclude valid questionnaire administration.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kaunas Hospital of the Lithuanian University of Health Sciences Coordinator of this site? Confirm its status | Kaunas | Lithuania | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.